Literature DB >> 23176872

CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils.

Robert G Townley1, Swati Agrawal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23176872     DOI： 10.1016/j.anai.2012.04.004

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  12 in total

Review 1.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

2.  Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.

Authors:  Eric Tyrell Oliver; Kris Chichester; Kelly Devine; Patricia Meghan Sterba; Craig Wegner; Becky Marie Vonakis; Sarbjit Singh Saini
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

3.  Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.

Authors:  David A Sandham; Lucy Barker; Lyndon Brown; Zarin Brown; David Budd; Steven J Charlton; Devnandan Chatterjee; Brian Cox; Gerald Dubois; Nicholas Duggan; Edward Hall; Julia Hatto; Janet Maas; Jodie Manini; Rachael Profit; Darren Riddy; Catherine Ritchie; Bindi Sohal; Duncan Shaw; Rowan Stringer; David A Sykes; Matthew Thomas; Katharine L Turner; Simon J Watson; Ryan West; Elisabeth Willard; Gareth Williams; Jennifer Willis
Journal:  ACS Med Chem Lett       Date:  2017-04-25       Impact factor: 4.345

Review 4.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

5.  Depletion of major pathogenic cells in asthma by targeting CRTh2.

Authors:  Tao Huang; Meredith Hazen; Yonglei Shang; Meijuan Zhou; Xiumin Wu; Donghong Yan; Zhonghua Lin; Margaret Solon; Elizabeth Luis; Hai Ngu; Yongchang Shi; Arna Katewa; David F Choy; Nandhini Ramamoorthi; Erick R Castellanos; Mercedesz Balazs; Min Xu; Wyne P Lee; Marissa L Matsumoto; Jian Payandeh; Joseph R Arron; Jo-Anne Hongo; Jianyong Wang; Isidro Hötzel; Cary D Austin; Karin Reif
Journal:  JCI Insight       Date:  2016-05-19

Review 6.  Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials.

Authors:  Gaurav Agnihotri; Peter A Lio
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

Review 7.  Lipid mediators and allergic diseases.

Authors:  Laura B Fanning; Joshua A Boyce
Journal:  Ann Allergy Asthma Immunol       Date:  2013-07-21       Impact factor: 6.347

8.  15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction.

Authors:  Line Nilsson; Fredrik Palm; Rikke Nørregaard
Journal:  Mediators Inflamm       Date:  2017-04-19       Impact factor: 4.711

Review 9.  Pathogenesis of Recalcitrant Chronic Rhinosinusitis: The Emerging Role of Innate Immune Cells.

Authors:  Il Gyu Kong; Dae Woo Kim
Journal:  Immune Netw       Date:  2018-02-13       Impact factor: 6.303

Review 10.  The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.

Authors:  Christian Domingo; Oscar Palomares; David A Sandham; Veit J Erpenbeck; Pablo Altman
Journal:  Respir Res       Date:  2018-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.